Robotic Surgery Recurring Revenue is Intuitive's operating measure combining instruments and accessories revenue, service revenue, and operating lease revenue.
Intuitive reported $8.465 billion of recurring revenue in 2025, up from $7.040 billion in 2024.
The decomposition
For 2025, the reported bridge is $6.019 billion of instruments and accessories revenue + $1.572 billion of service revenue + $874 million of operating lease revenue = $8.465 billion of recurring revenue. That decomposition links procedure demand, installed-base service, and leased-system usage to the recurring portion of the business.
Investor caution
Recurring revenue is an operating measure, not a separate GAAP revenue line that can be added to product and service revenue. Operating lease revenue is classified within systems revenue in Intuitive's financial statements and is also included in recurring revenue.
Source:
Part of the Robotic Surgery Platform Economics
See It in Company Research
These companies are examples of how the concept is reported or discussed in public filings. Definitions can differ by issuer; these links open company research rather than a normalized metric comparison.
- ISRGOpen operating-model research →17 of 17 reviewed concepts in Robotic Surgery Platform EconomicsRecurring installed-base monetization7 of 7 bridge concepts supportedContinue through this bridge:Instruments and Accessories RevenueInstruments and Accessories Revenue GrowthOperating Lease RevenueRecurring Revenue MixService RevenueService Revenue Growth
Continue Research
Continue from the concept into the Grizzly Bulls research surface that best matches the next question. These links are research continuations, not recommendations or required steps.
Compare medical device stocks
Continue into stock comparison for installed-base growth, procedure utilization, recurring revenue, and system-financing economics.
Explore more topics in the Financial Research Encyclopedia.